Sulzer pleased with second-quarter rise:
This article was originally published in Clinica
Sulzer Medica's second quarter saw a 6% sales increase after currency effects to SwFr338 million ($194 million). Its operating income was SwFr70 million - an 11% increase on the same quarter last year. The good figures continued in the first half, with sales up 7% to Swfr685 million and adjusted operating income up 13% to SwFr100 million. Mechanical heart valve sales increased in all regions and tissue valves in Europe contributed to a 12% first-half growth to SwFr123 million in the cardiovascular division, while orthopaedics grew an adjusted 6%, to SwFr562 million.